Lleida researcher Pau Marfull-Oromí, awarded with the Mark A. Smith Prize by the International Society for Neurochemistry for his research.

Lleida researcher Pau Marfull-Oromí, who completed his PhD at the Molecular and Developmental Neurobiology research group at the University of Lleida (UdL) and the Institute for Research in Biomedicine of Lleida (IRBLleida), has been awarded the third Mark A. Smith Prize 2021 for his research in the area of neurochemistry. The annual Mark A. Smith Award, inaugurated in 2009 by the International Society of Neurochemistry (ISN), highlights young scientists in recognition of their exceptional research work published in the international Journal of Neurochemistry, a reference in the field of neuroscience. 

Marfull-Oromí, who is currently working at the University of California in San Diego, USA, has been awarded for the publication "Genetic ablation of the Rho GTPase Rnd3 triggers developmental defects in internal capsule and the globus pallidus formation". The editors of the journal have highlighted "the elegant work that employs a comprehensive approach" to demonstrate an important role of the Rnd3 protein in brain development; specifically, in the regulation of axonal projections of the striatum (involved in motor control) and thalamocortical projections (involved in sensory activity).

The researcher has been awarded an invitation to present his research at the International Congress of the International Society for Neurochemistry, which will take place at the end of August in Honolulu, USA.

Text: Communication and Press IRBLleida

------

IRBLleida belongs to the Institution of Research Centres of Catalonia (I-CERCA), which is organised according to a model of good governance and operation that ensures the efficiency, management flexibility, attraction and promotion of talent, strategic planning and executive capacity of the research centres in Catalonia.